Back to calendar
Corvus Pharmaceuticals, Inc. (CRVS) Earnings
CRVS reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.16
Actual EPS: $-0.15
EPS surprise: -5.32%
Company overview
Market Cap$1.1B
PriceUSD 13.26
EPS (TTM)-0.53
52-week high26.95
52-week low4.05
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees37